Efficacy and Tolerability of Semaglutide in Patients With Type-2 Diabetes Mellitus: Experience of a Tertiary Care Hospital, Pakistan
Background: Semaglutide, a Glucagon-like peptide 1 (GLP-1) is highly effective as an anti-diabetic medication along with additional benefits of significant reduction in cardiovascular events and weight. Objectives: There is a lack of reliable evidence confirming the benefits of Semaglutide in the Pa...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2023-11-01
|
| Серія: | Clinical Medicine Insights: Endocrinology and Diabetes |
| Онлайн доступ: | https://doi.org/10.1177/11795514231213568 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|